DNMT3B and Miyoshi myopathy: Finally, we also validated the potent anti-MM activity of NA on human primary samples, showing higher selectivity towards MM cells than towards BM stromal cells, thus further confirming the therapeutic potential of DNMT3B targeting in MM.